[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN109265311B - Phenyl fluorene derivative and preparation method and application thereof - Google Patents

Phenyl fluorene derivative and preparation method and application thereof Download PDF

Info

Publication number
CN109265311B
CN109265311B CN201811305679.XA CN201811305679A CN109265311B CN 109265311 B CN109265311 B CN 109265311B CN 201811305679 A CN201811305679 A CN 201811305679A CN 109265311 B CN109265311 B CN 109265311B
Authority
CN
China
Prior art keywords
diphenylethylene
solvent
compound
equivalent
phenylfluorene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811305679.XA
Other languages
Chinese (zh)
Other versions
CN109265311A (en
Inventor
王利民
贺雨晨
姚峰
胡晨
杨阳
田禾
刘金库
韩建伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Zhaowei Technology Development Co ltd
East China University of Science and Technology
Original Assignee
Shanghai Zhaowei Technology Development Co ltd
East China University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Zhaowei Technology Development Co ltd, East China University of Science and Technology filed Critical Shanghai Zhaowei Technology Development Co ltd
Priority to CN201811305679.XA priority Critical patent/CN109265311B/en
Publication of CN109265311A publication Critical patent/CN109265311A/en
Application granted granted Critical
Publication of CN109265311B publication Critical patent/CN109265311B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/40Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals
    • C07C15/56Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals polycyclic condensed
    • C07C15/60Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals polycyclic condensed containing three rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C07C17/2637Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions between a compound containing only oxygen and possibly halogen as hetero-atoms and a halogenated hydrocarbon
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2/00Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms
    • C07C2/86Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms by condensation between a hydrocarbon and a non-hydrocarbon
    • C07C2/862Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms by condensation between a hydrocarbon and a non-hydrocarbon the non-hydrocarbon contains only oxygen as hetero-atoms
    • C07C2/864Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms by condensation between a hydrocarbon and a non-hydrocarbon the non-hydrocarbon contains only oxygen as hetero-atoms the non-hydrocarbon is an alcohol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/24Halogenated aromatic hydrocarbons with unsaturated side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/30Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/215Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2531/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • C07C2531/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • C07C2531/025Sulfonic acids
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a phenylfluorene derivative, which has a general formula shown in formula I:
Figure DDA0001853550830000011
in the formula I, R is selected from hydrogen, halogen, alkyl, alkoxy and aryl. The phenylfluorene derivative with a novel structure provided by the invention is simple in preparation method, mild in reaction conditions, non-toxic and harmless, has blue fluorescence, and can be used as a potential organic functional material.

Description

Phenyl fluorene derivative and preparation method and application thereof
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a 9-alkenyl-9-phenylfluorene derivative and a preparation method and application thereof.
Background
9, 9-diarylfluorenes are an important class of aromatic compounds. These compounds have now been found to be useful in electroluminescent devices or other applications. Spirocyclic fluorenes have also been studied extensively because of their unusual pi-systems used in organic light emitting diodes, light trapping arrays and organic electronic devices. The particular fluorene derivatives may also be coordinated with rare earth metals or transition metals to form new catalysts.
The 9-substituted 9-phenylfluorene derivative can be generally obtained from a 9-phenylfluorene cation via an electrophilic reaction. In 2017, the Klumpp topic group takes biphenyl-substituted heterocyclic ketone and aromatic hydrocarbon as substrates and takes trifluoromethanesulfonic acid as a solvent to react at normal temperature to obtain heterocycle-substituted 9, 9-diaryl fluorene (J.Org.chem.2017,82, 6044) -6053).
Figure BDA0001853550810000011
At present, few reports are made on the synthesis of 9-substituted 9-phenylfluorene compounds, and no document is published on 9-alkenyl-9-phenylfluorene compounds.
Disclosure of Invention
The invention aims to provide a phenylfluorene derivative with a novel structure, which has blue fluorescence and can be used as a potential organic functional material.
Another object of the present invention is to provide a method for preparing the phenylfluorene derivative having a novel structure.
It is still another object of the present invention to provide a use of the phenylfluorene derivative as an organic functional material.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
the invention provides a phenylfluorene derivative with a novel structure, which has a general formula shown in formula I:
Figure BDA0001853550810000021
in the formula I, R is selected from hydrogen, halogen, alkyl, alkoxy and aryl.
Preferred compounds of the invention are those of formula I wherein R is selected from hydrogen (H), halogen (F, Cl, Br), methyl (CH)3) Methoxy (OCH)3) Tert-butyl, phenyl
Figure BDA0001853550810000022
And the like.
The most preferred compound of the present invention is that the phenylfluorene derivative is selected from one of the following structures:
Figure BDA0001853550810000023
Figure BDA0001853550810000031
in the definition of formula I given above, the terms used in the collection are generally defined as follows:
the term alkyl refers to a straight or branched chain saturated aliphatic hydrocarbon group containing 1 to 7 carbon atoms, for example: methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, methylthio, ethylthio and the like.
The term alkoxy refers to a group having an oxygen atom attached to the alkyl terminus, for example: methoxy, ethoxy, n-propoxy, isopropoxy, and the like.
The term aryl refers to mono-, di-or tricyclic hydrocarbon compounds in which at least one ring is aromatic and each ring contains up to 7 carbon atoms, e.g. phenyl, naphthyl, anthracenyl, biphenyl or indenyl.
The term halogen means chlorine, bromine, iodine or fluorine.
Another aspect of the present invention provides a preparation method of the phenylfluorene derivative, including the steps of:
Figure BDA0001853550810000032
r is selected from hydrogen, halogen, alkyl, alkoxy and aryl;
mixing 1 equivalent of compound II-1 (9-phenylfluorene-9-ol) and 5% equivalent of catalyst, adding a proper solvent, then adding 1 equivalent of 1, 1-diphenylethylene compound III, reacting at 50-80 ℃ for 1-48 h, cooling to room temperature, spin-drying the solvent, and performing column chromatography separation and purification to obtain the compound phenylfluorene derivative shown in formula I.
The catalyst is at least one of scandium trifluoromethanesulfonate, aluminum trichloride, ferric trichloride, ytterbium trifluoromethanesulfonate and p-toluenesulfonic acid.
The solvent is at least one of 1, 2-dichloroethane, dichloromethane, chloroform and ethyl acetate.
The 1, 1-diphenylethylene compound III is selected from 1, 1-diphenylethylene, 4 '-dimethyl-1, 1-diphenylethylene, 4' -dimethoxy-1, 1-diphenylethylene, 4 '-di-tert-butyl-1, 1-diphenylethylene, 3' -dimethoxy-1, 1-diphenylethylene, 2,2 ' -dimethoxy-1, 1-diphenylethylene, 4 ' -difluoro-1, 1-diphenylethylene, 4 ' -dichloro-1, 1-diphenylethylene, 4 ' -dibromo-1, 1-diphenylethylene, 4 ' -diphenyl-1, 1-diphenylethylene.
The preparation method of the 1, 1-diphenylethylene compound III comprises the following steps:
Figure BDA0001853550810000041
r is selected from hydrogen, halogen, alkyl, alkoxy and aryl;
carrying out anhydrous and oxygen-free treatment on a 100mL three-neck round-bottom flask, adding redistilled tetrahydrofuran, 1 equivalent of ethyl acetate and 15% equivalent of copper oxide, then adding 3 equivalents of bromobenzene or bromobenzene substitute V and 3 equivalents of magnesium chips, reacting for 1-6 h at 50-80 ℃, monitoring the reaction completion by TLC, adding a saturated ammonium chloride solution into a system to quench the reaction, extracting with ethyl acetate, combining organic phases, washing with brine once, drying the organic phase with anhydrous sodium sulfate, removing the solvent of the organic phase, and separating by column chromatography to obtain a compound IV;
Figure BDA0001853550810000042
adding 10mmol of compound IV and 5 mol% of iodine into a 50mL single-neck flask, then adding acetonitrile serving as a solvent, reacting for 1-8 hours at room temperature, monitoring the reaction by TLC, removing the solvent, and separating by column chromatography to obtain the 1, 1-diphenylethylene compound III.
The bromobenzene substituent is one of the following structures:
Figure BDA0001853550810000051
the third aspect of the present invention provides a use of the phenylfluorene derivative as an organic functional material.
Due to the adoption of the technical scheme, the invention has the following advantages and beneficial effects:
the phenylfluorene derivative with a novel structure provided by the invention is simple in preparation method, mild in reaction conditions, non-toxic and harmless, has blue fluorescence, and can be used as a potential organic functional material.
Drawings
FIG. 1 is a fluorescence diagram of compounds I-4, I-5, I-8, I-9, and I-10 prepared in the examples of the present invention, which were subjected to fluorescence measurement.
Detailed Description
In order to more clearly illustrate the invention, the invention is further described below in connection with preferred embodiments. It is to be understood by persons skilled in the art that the following detailed description is illustrative and not restrictive, and is not to be taken as limiting the scope of the invention.
The reagents used in the invention are as follows: 9-phenylfluoren-9-ol, scandium trifluoromethanesulfonate, 1-diphenylethylene, 4 ' -dimethyl-1, 1-diphenylethylene, 4 ' -dimethoxy-1, 1-diphenylethylene, 4 ' -di-tert-butyl-1, 1-diphenylethylene, 3,3 '-dimethoxy-1, 1-diphenylethylene, 2' -dimethoxy-1, 1-diphenylethylene, 4 '-difluoro-1, 1-diphenylethylene, 4' -dichloro-1, 1-diphenylethylene, 4 '-dibromo-1, 1-diphenylethylene, 4' -diphenyl-1, 1-diphenylethylene;
the preparation method of the 9-phenylfluorene-9-alcohol comprises the following steps:
Figure BDA0001853550810000052
a100 mL three necked round bottom flask was treated with anhydrous oxygen free treatment, magnesium turnings (30mmol, 3 equiv.) and iodine (2mmol, 10% equiv.) were added, bromobenzene (30mmol, 1.5 equiv.) was dissolved in redistilled tetrahydrofuran and slowly added dropwise to the round bottom flask through a constant pressure dropping funnel for reaction at 65 ℃. After 2 hours, the 9-fluorenone was dissolved in tetrahydrofuran and slowly added to the reaction system, and the reaction was continued overnight. After the reaction is finished, adding saturated ammonium chloride solution into the system for quenching, then extracting with ethyl acetate (3X 30mL), combining organic phases, washing once with brine, then drying the organic phases with anhydrous sodium sulfate, removing the solvent of the organic phases, and obtaining the 9-phenylfluorene-9-alcohol through column chromatography separation.
The preparation method of the 1, 1-diphenylethylene compound III with different substituents comprises the following steps:
Figure BDA0001853550810000061
a100 mL three necked round bottom flask was treated with anhydrous oxygen free treatment, followed by addition of 30mL of redistilled tetrahydrofuran, ethyl acetate (10mmol, 1 equiv.), 1.5mmol of copper oxide (15% equiv.), and then bromobenzene or a bromobenzene substituent V (30mmol, 3 equiv.) and magnesium turnings (30mmol, 3 equiv.) and reacted at 60 ℃ for 4 h. When the reaction was terminated by TLC, a saturated ammonium chloride solution was added to the system to quench the reaction, and the reaction was extracted with ethyl acetate (3 × 30mL), and the organic phases were combined, washed once with brine, and then dried over anhydrous sodium sulfate to remove the solvent from the organic phase, and separated by column chromatography to give compound IV.
Figure BDA0001853550810000062
Adding a compound IV (10mmol) and iodine (5 mol%) into a 50mL single-neck flask, then adding a solvent acetonitrile, reacting for 6 hours at room temperature, monitoring the reaction by TLC, removing the solvent, and separating by column chromatography to obtain the 1, 1-diphenylethylene compound III with different substituents.
In the above reaction, R is hydrogen (H), halogen (F, Cl, Br), methyl (CH)3) Methoxy (OCH)3) Tert-butyl, phenyl
Figure BDA0001853550810000063
And the like.
Reagents used in the examples of the present invention: 9-fluorenone, 25g, purity ≥ 98.0%, available from Shanghai Dairy Fine Chemicals, Inc.; 1, 1-diphenylethylene, 5g, 98% purity, available from Hadamard reagent, Inc.; 500mL of bromobenzene, analytically pure, purchased from national pharmaceutical group reagents, Inc.; 500g of copper oxide, analytically pure, purchased from chemical reagents of national drug group, ltd; magnesium turnings, 500g, analytically pure, were purchased from national pharmaceutical group chemical reagents, Inc.
Example 1
Figure BDA0001853550810000071
Mixing 9-phenylfluoren-9-ol (compound II-1, 0.25mmol, 1 equiv.) and scandium trifluoromethanesulfonate (0.0125mmol, 5 mol% equiv.), adding 2mL of 1, 2-dichloroethane as a solvent, adding 1, 1-diphenylethylene (compound III-1, 0.25mmol, 1 equiv.), reacting at 60 deg.C for 12 hours, cooling to room temperature, spin-drying the solvent, and purifying by column chromatography on a dry column (eluent: petroleum ether: ethyl acetate: 100: 2) to obtain the target product (compound I-1) as a white solid with a yield of 95%.
1H NMR(400MHz,CDCl3)δ7.44(d,J=7.5Hz,2H),7.35–7.28(m,2H),7.27–7.14(m, 13H),7.09–7.00(m,2H),6.89–6.79(m,1H),6.76–6.65(m,2H),6.36–6.13(m,2H).
Example 2
Figure BDA0001853550810000072
Mixing 9-phenylfluoren-9-ol (compound II-1, 0.25mmol, 1 equiv.) and scandium trifluoromethanesulfonate (0.0125mmol, 5 mol% equiv.), adding 2mL of 1, 2-dichloroethane as a solvent, adding 4, 4' -dimethyl-1, 1-diphenylethylene (compound III-2, 0.25mmol, 1 equiv.), reacting at 60 ℃ for 12 hours, cooling to room temperature, spin-drying the solvent, and purifying by column chromatography (eluent: petroleum ether: ethyl acetate: 100: 2) to obtain the target product (compound I-2) as a white solid with a yield of 94%.
1H NMR(400MHz,CDCl3)δ7.45(d,J=7.5Hz,2H),7.29(d,J=7.4Hz,2H),7.26–7.19 (m,2H),7.19–7.11(m,7H),7.08(s,1H),7.07–6.97(m,4H),6.49(d,J=7.7Hz,2H),6.13(d,J =7.8Hz,2H),2.30(s,3H),2.12(s,3H).
Example 3
Figure BDA0001853550810000081
Mixing 9-phenylfluoren-9-ol (compound II-1, 0.25mmol, 1 equiv.) and scandium trifluoromethanesulfonate (0.0125mmol, 5 mol% equiv.), adding 2mL of 1, 2-dichloroethane as a solvent, adding 4, 4' -dimethoxy-1, 1-diphenylethylene (compound III-3, 0.25mmol, 1 equiv.), reacting at 60 ℃ for 12 hours, cooling to room temperature, spin-drying the solvent, and purifying by column chromatography (eluent: petroleum ether: ethyl acetate: 100: 1) to obtain the target product (compound I-3) as a white solid with a yield of 83%.
1H NMR(400MHz,CDCl3)δ7.52–7.44(m,2H),7.31–7.27(m,2H),7.26–7.22(m,2H), 7.20–7.13(m,7H),7.08–7.00(m,3H),6.81–6.74(m,2H),6.27–6.21(m,2H),6.18–6.11(m, 2H),3.76(s,3H),3.66(s,3H).
Example 4
Figure BDA0001853550810000091
Mixing 9-phenylfluoren-9-ol (compound II-1, 0.25mmol, 1 equiv.) and scandium trifluoromethanesulfonate (0.0125mmol, 5 mol% equiv.), adding 2mL of 1, 2-dichloroethane as a solvent, adding 4, 4' -di-tert-butyl-1, 1-diphenylethylene (compound III-4, 0.25mmol, 1 equiv.), reacting at 60 deg.C for 12 hours, cooling to room temperature, spin-drying the solvent, and purifying by column chromatography (eluent: petroleum ether: ethyl acetate: 100: 2) to obtain the target product (compound I-4) as a white solid with a yield of 93%.
1H NMR(400MHz,CDCl3)δ7.40(d,J=7.5Hz,2H),7.34–7.11(m,14H),7.02(dd,J=8.0, 6.9Hz,2H),6.68(d,J=8.1Hz,2H),6.14(d,J=8.0Hz,2H),1.28(s,9H),1.20(s,9H).
Example 5
Figure BDA0001853550810000092
Mixing 9-phenylfluoren-9-ol (compound II-1, 0.25mmol, 1 equiv.) and scandium trifluoromethanesulfonate (0.0125mmol, 5 mol% equiv.), adding 2mL of 1, 2-dichloroethane as a solvent, adding 3, 3' -dimethoxy-1, 1-diphenylethylene (compound III-5, 0.25mmol, 1 equiv.), reacting at 60 ℃ for 12 hours, cooling to room temperature, spin-drying the solvent, and purifying by column chromatography (eluent: petroleum ether: ethyl acetate: 100: 1) to obtain the target product (compound I-5) as a white solid with a yield of 93%.
1H NMR(400MHz,CDCl3)δ7.50–7.41(m,2H),7.33–7.27(m,2H),7.27–7.13(m,9H), 7.10–7.01(m,2H),6.90–6.83(m,1H),6.81–6.72(m,2H),6.65(m,1H),6.45–6.35(m,1H), 5.96–5.88(m,1H),5.72(m,1H),3.72(s,3H),3.44(s,3H).
Example 6
Figure BDA0001853550810000101
Mixing 9-phenylfluoren-9-ol (compound II-1, 0.25mmol, 1 equiv.) and scandium trifluoromethanesulfonate (0.0125mmol, 5 mol% equiv.), adding 2mL of 1, 2-dichloroethane as a solvent, adding 2, 2' -dimethoxy-1, 1-diphenylethylene (compound III-6, 0.25mmol, 1 equiv.), reacting at 60 ℃ for 12 hours, cooling to room temperature, spin-drying the solvent, and purifying by column chromatography (eluent: petroleum ether: ethyl acetate: 100: 1) to obtain the target product (compound I-6) as a white solid with a yield of 94%.
1H NMR(400MHz,CDCl3)δ7.40–7.31(m,4H),7.27–7.08(m,8H),7.05–6.94(m,4H), 6.87(d,J=8.2Hz,1H),6.81–6.73(m,2H),6.36–6.21(m,2H),6.16(d,J=8.2Hz,1H),3.80(s, 3H),3.29(s,3H).
Example 7
Figure BDA0001853550810000102
Mixing 9-phenylfluoren-9-ol (compound II-1, 0.25mmol, 1 equiv.) and scandium trifluoromethanesulfonate (0.0125mmol, 5 mol% equiv.), adding 2mL of 1, 2-dichloroethane as a solvent, adding 4, 4' -difluoro-1, 1-diphenylethylene (compound III-7, 0.25mmol, 1 equiv.), reacting at 60 ℃ for 12 hours, cooling to room temperature, spin-drying the solvent, and purifying by column chromatography (eluent: petroleum ether: ethyl acetate: 100: 2) to obtain the target product (compound I-7) as a white solid with a yield of 77%.
1H NMR(400MHz,CDCl3)δ7.46(m,2H),7.32–7.12(m,12H),7.11–7.04(m,2H),6.97– 6.88(m,2H),6.44–6.35(m,2H),6.21–6.11(m,2H).
Example 8
Figure BDA0001853550810000111
Mixing 9-phenylfluoren-9-ol (compound II-1, 0.25mmol, 1 equiv.) and scandium trifluoromethanesulfonate (0.0125mmol, 5 mol% equiv.), adding 2mL of 1, 2-dichloroethane as a solvent, adding 4, 4' -dichloro-1, 1-diphenylethylene (compound III-8, 0.25mmol, 1 equiv.), reacting at 60 ℃ for 12 hours, cooling to room temperature, spin-drying the solvent, and purifying by column chromatography (eluent: petroleum ether: ethyl acetate: 100: 2) to obtain the target product (compound I-8) as a white solid with a yield of 84%.
1H NMR(400MHz,CDCl3)δ7.53–7.44(m,2H),7.31–7.17(m,11H),7.16(s,1H),7.14– 7.03(m,4H),6.70–6.61(m,2H),6.18–6.07(m,2H).
Example 9
Figure BDA0001853550810000121
Mixing 9-phenylfluoren-9-ol (compound II-1, 0.25mmol, 1 equiv.) and scandium trifluoromethanesulfonate (0.0125mmol, 5 mol% equiv.), adding 2mL of 1, 2-dichloroethane as a solvent, adding 4, 4' -dibromo-1, 1-diphenylethylene (compound III-9, 0.25mmol, 1 equiv.), reacting at 60 ℃ for 12 hours, cooling to room temperature, spin-drying the solvent, and purifying by column chromatography (eluent: petroleum ether: ethyl acetate: 100: 2) to obtain the target product (compound I-9) as a white solid with a yield of 82%.
1H NMR(400MHz,CDCl3)δ7.47(s,2H),7.38–7.32(m,2H),7.30–7.16(m,9H),7.15(s, 1H),7.12–7.03(m,4H),6.86–6.79(m,2H),6.10–6.02(m,2H).
Example 10
Figure BDA0001853550810000122
Mixing 9-phenylfluoren-9-ol (compound II-1, 0.25mmol, 1 equiv.) and scandium trifluoromethanesulfonate (0.0125mmol, 5 mol% equiv.), adding 2mL of 1, 2-dichloroethane as a solvent, adding 4, 4' -diphenyl-1, 1-diphenylethylene (compound III-10, 0.25mmol, 1 equiv.), reacting at 60 ℃ for 12 hours, cooling to room temperature, spin-drying the solvent, and purifying by column chromatography (eluent: petroleum ether: ethyl acetate: 100: 3) to obtain the target product (compound I-10) as a white solid with a yield of 99%.
1H NMR(400MHz,CDCl3)δ7.60–7.53(m,2H),7.52–7.47(m,2H),7.46–7.39(m,8H), 7.36–7.30(m,6H),7.29–7.15(m,9H),7.10–7.02(m,2H),6.97–6.89(m,2H),6.38–6.29(m, 2H).
The compounds I-4, I-5, I-8, I-9 and I-10 were subjected to fluorescence test, as shown in FIG. 1, FIG. 1 is a schematic diagram of fluorescence of compounds I-4, I-5, I-8, I-9 and I-10 prepared in the example of the present invention, with an excitation wavelength of 310nm, a scanning range of 200 and 650nm, and a scanning interval of 5 nm. As can be seen from the figure, all the products have a strong fluorescence emission peak at 320-350 nm, and the peak positions are different due to different functional groups of the compounds. In addition, the product I-8 has a strong fluorescence peak around 440 nm.
The foregoing shows and describes the general principles, essential features, and advantages of the invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are given by way of illustration of the principles of the present invention, and that various changes and modifications may be made without departing from the spirit and scope of the invention as defined by the appended claims. The scope of the invention is defined by the appended claims and equivalents thereof.

Claims (3)

1. A phenylfluorene derivative is characterized in that the phenylfluorene derivative is one of the following compounds:
Figure FDA0003028011830000011
2. a process for preparing a phenylfluorene derivative according to claim 1, which comprises the main steps of: mixing 1 equivalent of the compound II-1 with 5% equivalent of a catalyst, adding a proper solvent, then adding 1 equivalent of the 1, 1-diphenylethylene compound III, reacting at 50-80 ℃ for 1-48 h, cooling to room temperature, spin-drying the solvent, and performing column chromatography separation and purification to obtain a target compound;
Figure FDA0003028011830000012
wherein, the 1, 1-diphenylethylene compound III is 4,4 '-di-tert-butyl-1, 1-diphenylethylene, 3, 3' -dimethoxy-1, 1-diphenylethylene, 4,4 '-dichloro-1, 1-diphenylethylene or 4, 4' -diphenyl-1, 1-diphenylethylene;
the catalyst is at least one of scandium trifluoromethanesulfonate, aluminum trichloride, ferric trichloride, ytterbium trifluoromethanesulfonate or p-toluenesulfonic acid;
the solvent is at least one of 1, 2-dichloroethane, dichloromethane, chloroform or ethyl acetate.
3. The process according to claim 2, wherein the 1, 1-diphenylethylene compound III is prepared by a preparation process comprising the steps of:
carrying out anhydrous and oxygen-free treatment on a 100mL three-neck round-bottom flask, adding redistilled tetrahydrofuran, 1 equivalent of ethyl acetate and 15% equivalent of copper oxide, then adding 3 equivalent of bromobenzene substituent V and 3 equivalent of magnesium chips, reacting for 1-6 h at 50-80 ℃, monitoring that a raw material point disappears by TLC, adding saturated ammonium chloride solution into a system to quench the reaction, extracting with ethyl acetate, combining organic phases, washing with brine once, drying the organic phase with anhydrous sodium sulfate, removing a solvent of the organic phase, and separating by column chromatography to obtain a compound IV;
adding 10mmol of compound IV and 5 mol% of iodine into a 50mL single-neck flask, then adding solvent acetonitrile, reacting for 1-8 h at room temperature, detecting the disappearance of a raw material point by TLC, removing the solvent, and separating by column chromatography to obtain a target substance;
Figure FDA0003028011830000021
wherein the bromobenzene substituent V is one of the following compounds:
Figure FDA0003028011830000022
CN201811305679.XA 2018-11-05 2018-11-05 Phenyl fluorene derivative and preparation method and application thereof Active CN109265311B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811305679.XA CN109265311B (en) 2018-11-05 2018-11-05 Phenyl fluorene derivative and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811305679.XA CN109265311B (en) 2018-11-05 2018-11-05 Phenyl fluorene derivative and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN109265311A CN109265311A (en) 2019-01-25
CN109265311B true CN109265311B (en) 2021-06-04

Family

ID=65191842

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811305679.XA Active CN109265311B (en) 2018-11-05 2018-11-05 Phenyl fluorene derivative and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN109265311B (en)

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"A simple and efficient copper oxide-catalyzed Barbier–Grignard reaction of unactivated aryl or alkyl bromides with ester";Fei Gao等,;《Tetrahedron Letters》;20140122;第55卷(第4期);第881页Table2 *
"Iodine-catalyzed Transformation of Aryl-substituted Alcohols Under Solvent-free and Highly Concentrated Reaction Conditions";Marjan Jereb等,;《Acta Chimica Slovenica》;20171201;第64卷(第4期);第751页Table1 *
"Lewis base-assisted Lewis acid-catalyzed selective alkene formation via alcohol dehydration and synthesis of 2-cinnamyl-1,3-dicarbonyl compounds from 2-aryl-3,4-dihydropyrans";Changhui Liu等,;《Chinese Journal of Catalysis》;20160615;第37卷(第6期);第979-986页第983页Scheme3 *
"STN登记号1098260-38-8的化合物";STN Registry数据库,;《STN》;20090201;第2页化合物1098260-38-8 *
"STN登记号861554-89-4的化合物";STN Registry数据库,;《STN》;20050824;第2页化合物861554-89-4、第4页第13行 *
"STN登记号904061-79-6的化合物";STN Registry数据库,;《STN》;20060824;第2页化合物904061-79-6 *

Also Published As

Publication number Publication date
CN109265311A (en) 2019-01-25

Similar Documents

Publication Publication Date Title
CN111094223B (en) binaphthyl compounds
CN109265311B (en) Phenyl fluorene derivative and preparation method and application thereof
CN110078653B (en) Indole-substituted 9-phenylfluorene derivative and preparation method and application thereof
CN115073495B (en) Indoline compound and preparation method thereof
Kajanus et al. Synthesis of bis (phenylethynyl) arylene-linked diporphyrins designed for studies of intramolecular energy transfer
CN115260205B (en) Bipyrene-doped extended porphyrin, bipropylar metal complex thereof, preparation method and application thereof
CN108558595B (en) P-phenylene ethylene bridged trimer indene derivative and preparation method thereof
JP2019085385A (en) Method for preparing indenoisoquinoline derivative
CN115304618A (en) Chiral thiophene spiroalkene based on triptycene and preparation method thereof
CN110240572B (en) Synthesis method of trans-1, 1-cyclopropane dicarboxylic acid ester
JP2012176928A (en) Pyrene derivative, production method of pyrene derivative, complex, catalyst, electronic material, light-emitting material and pigment
CN114149307A (en) Bromopyrene intermediate and derivative, preparation method and application thereof
CN109134345A (en) 15- hexyl-tetraphenyl simultaneously [1,2-b] carbazole aromatic fused ring compound and its synthetic method
JP5899110B2 (en) Method for producing diaryl derivative, novel binaphthyl derivative, method for producing arene derivative, and novel arene derivative
CN107603271B (en) Preparation method of long-chain alkoxy BODIPY compound
CN112047815A (en) Preparation method of cannabidiol compound
CN111233616A (en) Pyrenyl [4] helicene and synthesis method and application thereof
CN111393869A (en) Fluorescent dye containing phenylethynyl naphthalene, preparation method and application thereof
CN111559973B (en) Spiroalkene derivative and preparation method and application thereof
CN111732532B (en) Method for synthesizing tetra-aryl substituted ethylene derivative with electron-deficient group
CN113121543B (en) Preparation method of azepine [4,5-b ] indole compound
CN109384786A (en) imidazole-based isomer luminescent molecule and preparation method and application thereof
CN109232169A (en) A kind of polyaryl replaces fulvalene compound and its synthetic method
JP2015040176A (en) Bis-borondipyrromethene dye
CN113880870B (en) Pyridine fluorine boron fluorescent dye compound and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant